Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-10

Clinical Trial Update: Methotrexate in Retinal Detachment With Proliferative Vitreoretinopathy [NA]

View source ↗

Summary

Clinical trial evaluating methotrexate for retinal detachment with proliferative vitreoretinopathy has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Benha University | Conditions: Retinal Detachment | NA | Status: COMPLETED